Inalways (TWO:5398) — Market Cap & Net Worth
Market Cap & Net Worth: Inalways (5398)
Inalways (TWO:5398) has a market capitalization of $31.48 Million (NT$999.20 Million) as of May 4, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #23560 globally and #1491 in its home market, demonstrating a -2.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inalways's stock price NT$20.20 by its total outstanding shares 49465460 (49.47 Million). Analyse how efficiently does Inalways generate cash to see how efficiently the company converts income to cash.
Inalways Market Cap History: 2015 to 2026
Inalways's market capitalization history from 2015 to 2026. Data shows growth from $29.69 Million to $31.48 Million (0.32% CAGR).
Inalways Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inalways's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.18x
Inalways's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.33x
Inalways's market cap is 2.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $62.83 Million | $333.78 Million | $8.94 Million | 0.19x | 7.03x |
| 2017 | $46.48 Million | $544.25 Million | $18.04 Million | 0.09x | 2.58x |
| 2018 | $31.45 Million | $531.38 Million | -$62.14 Million | 0.06x | N/A |
| 2019 | $39.75 Million | $432.97 Million | $25.33 Million | 0.09x | 1.57x |
| 2020 | $29.63 Million | $367.88 Million | $16.66 Million | 0.08x | 1.78x |
| 2021 | $31.33 Million | $351.56 Million | $16.21 Million | 0.09x | 1.93x |
| 2022 | $25.56 Million | $257.55 Million | -$6.79 Million | 0.10x | N/A |
| 2023 | $23.77 Million | $192.90 Million | -$31.81 Million | 0.12x | N/A |
| 2024 | $30.31 Million | $238.48 Million | $8.75 Million | 0.13x | 3.46x |
| 2025 | $40.52 Million | $229.85 Million | $17.36 Million | 0.18x | 2.33x |
Competitor Companies of 5398 by Market Capitalization
Companies near Inalways in the global market cap rankings as of May 4, 2026.
Key companies related to Inalways by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Inalways Historical Marketcap From 2015 to 2026
Between 2015 and today, Inalways's market cap moved from $29.69 Million to $ 31.48 Million, with a yearly change of 0.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$31.48 Million | -22.31% |
| 2025 | NT$40.52 Million | +33.68% |
| 2024 | NT$30.31 Million | +27.54% |
| 2023 | NT$23.77 Million | -7.01% |
| 2022 | NT$25.56 Million | -18.42% |
| 2021 | NT$31.33 Million | +5.72% |
| 2020 | NT$29.63 Million | -25.45% |
| 2019 | NT$39.75 Million | +26.38% |
| 2018 | NT$31.45 Million | -32.34% |
| 2017 | NT$46.48 Million | -26.01% |
| 2016 | NT$62.83 Million | +111.62% |
| 2015 | NT$29.69 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Inalways was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $31.48 Million USD |
| MoneyControl | $31.48 Million USD |
| MarketWatch | $31.48 Million USD |
| marketcap.company | $31.48 Million USD |
| Reuters | $31.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Inalways
Mediera Corporation manufactures electronic and power supply components in Taiwan. It is also involved in the medical biotechnology business. The company offers medicines, health food, and medical device, etc. Mediera Corporation was founded in 1967 and is based in New Taipei City, Taiwan.